J R Marshall
Overview
Explore the profile of J R Marshall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
292
Citations
3561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dworkin J, Adelman L, Ajluni T, Andronikov A, Aponte J, Bartels A, et al.
Space Sci Rev
. 2019 Feb;
214(1).
PMID: 30713357
OSIRIS-REx will return pristine samples of carbonaceous asteroid Bennu. This article describes how pristine was defined based on expectations of Bennu and on a realistic understanding of what is achievable...
2.
Cheng J, Ondracek R, Mehedint D, Kasza K, Xu B, Gill S, et al.
Prostate Cancer Prostatic Dis
. 2015 Apr;
18(2):182-9.
PMID: 25868764
Background: Fatty-acid synthase (FASN), selectively overexpressed in prostate cancer (PCa) cells, has been described as linked to the aggressiveness of PCa. Constitutional genetic variation of the FASN gene and the...
3.
Genkinger J, Wang M, Li R, Albanes D, Anderson K, Bernstein L, et al.
Ann Oncol
. 2014 Mar;
25(6):1106-15.
PMID: 24631943
Pancreatic cancer has few early symptoms, is usually diagnosed at late stages, and has a high case-fatality rate. Identifying modifiable risk factors is crucial to reducing pancreatic cancer morbidity and...
4.
Marshall J
Med Teach
. 2014 Feb;
1(4):190-4.
PMID: 24483219
This paper provides an overview of various methods that have been developed to help students learn procedural skills. Future issues of Medical Teacher will describe each of the methods in...
5.
Marshall J
J Prim Prev
. 2013 Nov;
17(1):99-115.
PMID: 24254923
Marshall's paper delves into the myths about schizophrenia and the growth of biologic and genetic explanations based on political manufacture of "knowledge."
6.
Mannava S, Omilian A, Wawrzyniak J, Fink E, Zhuang D, Miecznikowski J, et al.
Oncogene
. 2011 Aug;
31(12):1484-92.
PMID: 21822300
Oncoprotein C-MYC is overexpressed in human metastatic melanomas and melanoma-derived cells where it is required for the suppression of oncogene-induced senescence (OIS). The genetic events that maintain high levels of...
7.
Martinez M, Sampliner R, Marshall J, Bhattacharyya A, Reid M, Alberts D
Gastroenterology
. 2004 Apr;
120(5):1077-83.
PMID: 11266371
Background And Aims: The link between adenoma characteristics at baseline colonoscopy and adenoma recurrence is poorly understood. We assessed whether the number, size, location, or histology of resected adenomas was...
8.
Stratton M, Reid M, Schwartzberg G, Minter F, Monroe B, Alberts D, et al.
Anticancer Drugs
. 2003 Sep;
14(8):595-600.
PMID: 14501381
Impediment of the promotion and progression stages of carcinogenesis of the prostate could have a profound impact on treatment choice and prognosis for prostate cancer. Efficacious chemopreventive agents that elicit...
9.
Stratton M, Reid M, Schwartzberg G, Minter F, Monroe B, Alberts D, et al.
Anticancer Drugs
. 2003 Sep;
14(8):589-94.
PMID: 14501380
Epidemiological and clinical studies suggesting a significant inverse relationship between intake of dietary selenium and overall cancer risk have led to initiation of a randomized, placebo-controlled, phase III clinical trial...
10.
Duffield-Lillico A, Dalkin B, Reid M, Turnbull B, Slate E, Jacobs E, et al.
BJU Int
. 2003 Apr;
91(7):608-12.
PMID: 12699469
Objective: To present the results (to January 1996, the end of blinded treatment) of the Nutritional Prevention of Cancer (NPC) Trial, a randomized trial of selenium (200 micro g daily)...